{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T22:51:14Z","timestamp":1695768674434},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"S11","license":[{"start":{"date-parts":[[1985,11,1]],"date-time":"1985-11-01T00:00:00Z","timestamp":499651200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Digest Dis Sci"],"published-print":{"date-parts":[[1985,11]]},"DOI":"10.1007\/bf01309384","type":"journal-article","created":{"date-parts":[[2005,3,25]],"date-time":"2005-03-25T23:12:29Z","timestamp":1111792349000},"page":"43S-51S","source":"Crossref","is-referenced-by-count":10,"title":["Pharmacology of the treatment of peptic ulcer disease"],"prefix":"10.1007","volume":"30","author":[{"given":"G.","family":"Bertaccini","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Coruzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/236385a0","volume":"236","author":"JW Black","year":"1972","unstructured":"Black JW, Duncan WAM, Durant CJ, Ganellin CR, Parsons ME: Definition and antagonism of histamine H2-receptors. Nature 236:385?390, 1972","journal-title":"Nature"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1016\/0024-3205(82)90066-2","volume":"31","author":"R Hammer","year":"1982","unstructured":"Hammer R, Giachetti A: Muscarinic receptor subtypes: M1 and M2. Biochemical and functional characterization. Life Sci 31:2991?2998, 1982","journal-title":"Life Sci"},{"key":"CR3","unstructured":"Hirschowitz BI, Hammer R, Giachetti A, Keirns JJ, Levine RR: Subtypes of muscarinic receptors. TIPS (Suppl), 1984, 103 p"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0014-2999(82)90404-6","volume":"86","author":"GC Rosenfeld","year":"1982","unstructured":"Rosenfeld GC: Pirenzepine (LS 519): a weak inhibitor of acid secretion by isolated rat parietal cells. Eur J Pharmacol 86:99?101, 1982","journal-title":"Eur J Pharmacol"},{"key":"CR5","first-page":"246","volume":"30","author":"G Dobrilla","year":"1983","unstructured":"Dobrilla G, Lucchin L, Comberlato M, Coruzzi G, Bertacini G: Pirenzepine and exocrine secretions: a selective agent for gastric glands? Hepato-gastroenterology 30:246?248, 1983","journal-title":"Hepato-gastroenterology"},{"issue":"Suppl 83","key":"CR6","first-page":"82","volume":"18","author":"JH Baron","year":"1983","unstructured":"Baron JH, Londong W: Advances in basic and clinical pharmacology of pirenzepine. Scand J Gastroenterol 18 (Suppl 83):82, 1983","journal-title":"Scand J Gastroenterol"},{"issue":"Suppl 72","key":"CR7","first-page":"273","volume":"17","author":"G Dotevall","year":"1982","unstructured":"Dotevall G, Jaup BH, Stockbrugger RW: On the selectivity of antimuscarinic compounds. Scand J Gastroenterol 17 (Suppl 72):273, 1982","journal-title":"Scand J Gastroenterol"},{"key":"CR8","unstructured":"Receptor update, Int Symp Sidney, Australia, Oct 18, 1982, 154 pp"},{"key":"CR9","first-page":"195","volume-title":"Highlights in Receptor, Chemistry","author":"JP Buyniski","year":"1984","unstructured":"Buyniski JP, Cavanagh RL, Pircio AW, Algieri AA, Crenshaw RR.In Highlights in Receptor, Chemistry, C Melchiorre, M Gianella (eds). Amsterdam, Elsevier, 1984, pp 195?213"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/B978-0-7236-0589-8.50008-9","volume-title":"Pharmacology of Histamine Receptors","author":"CR Ganellin","year":"1982","unstructured":"Ganellin CR: Chemistry and structure-activity relationships of drugs acting as histamine receptors.In Pharmacology of Histamine Receptors, CR Ganellin, ME Parsons (eds). Bristol, Wright PSG, 1982, pp 10?102"},{"key":"CR11","first-page":"392","volume-title":"Cimetidine","author":"WL Burland","year":"1977","unstructured":"Burland WL, Alison Simkins M: Cimetidine. Amsterdam, Excerpta Medica, 392, 1977"},{"key":"CR12","first-page":"302","volume-title":"Cimetidine","author":"C Wastell","year":"1978","unstructured":"Wastell C, Lance P: Cimetidine, Edinburgh, Churchill Livingstone, 302, 1978"},{"key":"CR13","first-page":"285","volume-title":"Cimetidine in the 80s","author":"JH Baron","year":"1981","unstructured":"Baron JH: Cimetidine in the 80s. Edinburgh, Churchill Livingstone, 285, 1981"},{"key":"CR14","first-page":"314","volume-title":"The Clinical Use of Ranitidine","author":"JJ Misiewicz","year":"1982","unstructured":"Misiewicz JJ, Wormsley KG: The Clinical Use of Ranitidine. Oxford, The Medical Publishing Foundation, 1982, 314 pp"},{"key":"CR15","first-page":"227","volume-title":"Ranitidine","author":"AJ Riley","year":"1982","unstructured":"Riley AJ, Salmon PR: Ranitidine. Amsterdam, Excerpta Medica, 1982, 227 pp"},{"key":"CR16","first-page":"119","volume":"16","author":"G Bertaccini","year":"1984","unstructured":"Bertaccini G, Coruzzi G: H2-receptor antagonists: side effects and adverse effects. Ital J Gastroenterol 16:119?125, 1984","journal-title":"Ital J Gastroenterol"},{"key":"CR17","unstructured":"Ranitidine Therapeutic Advances, Int Symp London, March 9, 1984"},{"key":"CR18","unstructured":"Cimetidine Today, Int Symp Rome, May 15, 1984"},{"key":"CR19","unstructured":"Dittler J, Reimann HJ, Schmidt U: The circadian rhythm of histamine. Eur Hist Res Soc 130 Meeting, abs p 14, Florence, May 16?19, 1984"},{"key":"CR20","unstructured":"Workshop on modern treatment of peptic ulcer disease and further developments in H2-antagonists. It J Gastroenterol 16:165?182, 1984"},{"key":"CR21","unstructured":"Bertaccini G, Coruzzi G: Interaction between histamine H2-receptor antagonists and the cholinergic system. Drug Ther (Special Suppl):9?19, 1984"},{"key":"CR22","unstructured":"Marks IN, Samloff IM, Aarimaa M, Siurala M: Proceedings of the 2nd International Sucralfate Symposium. Scand J Gastroenterol 18(snSuppl 83): 1983, 82 pp"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0016-5085(82)80385-5","volume":"82","author":"F Martin","year":"1982","unstructured":"Martin F, Farley A, Gagnon M, Bensemana D: Comparison of healing capacities of sucralfate and cimetidine in short treatment of duodenal ulcer. Double blind randomized trial. Gastroenterology 82:401?405, 1982","journal-title":"Gastroenterology"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"808","DOI":"10.5694\/j.1326-5377.1977.tb131140.x","volume":"1","author":"SP Lee","year":"1977","unstructured":"Lee SP, Nicholson GI: Increased healing of gastric and duodenal ulcers in a controlled trial using tripotassium dicitrato bismuthate. Med J Aust 1:808?812, 1977","journal-title":"Med J Aust"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(81)90114-8","volume":"1","author":"DF Martin","year":"1981","unstructured":"Martin DF, Hollander D, Maj SJ, Ravenscroft MM, Tweedle DEF, Miller JP: Differences in relapse rates of duodenal ulcer after healing with cimetidine or tripotassium dicitrato bismuthate. Lancet 1:7?10, 1981","journal-title":"Lancet"},{"key":"CR26","volume-title":"Peptic ulcer healing","author":"F Avery Jones","year":"1978","unstructured":"Avery Jones F, Langman MJS, Mann RD: Peptic ulcer healing, Lancaster, MTP Press, 1978, 151 pp"},{"key":"CR27","first-page":"1157","volume":"49","author":"MG Moshal","year":"1975","unstructured":"Moshal MG: Trials with metoclopramide in duodenal ulceration. S Afr Med J 49:1157?1159, 1975","journal-title":"S Afr Med J"},{"key":"CR28","first-page":"19","volume-title":"Recent drugs in gastroenterology","author":"G Bertaccini","year":"1983","unstructured":"Bertaccini G, Coruzzi G: Recent drugs in gastroenterology.In: G Dobrilla, C, Liguory, G Misiewicz (eds). New York, Raven Press, 1983, pp 19?27"},{"key":"CR29","first-page":"897","volume":"70","author":"ED Jacobson","year":"1976","unstructured":"Jacobson ED, Chaudhury TK, Thompson WJ: Mechanism of gastric mucosal cytoprotection by prostaglandins. Gastroenterology 70:897, 1976","journal-title":"Gastroenterology"},{"key":"CR30","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/0016-5085(79)90235-X","volume":"77","author":"A Robert","year":"1979","unstructured":"Robert A: Cytoprotection by prostaglandins. Gastroenterology 77:761?767, 1979","journal-title":"Gastroenterology"},{"key":"CR31","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000198946","volume":"27","author":"SJ Konturek","year":"1983","unstructured":"Konturek SJ, Brzozowski T, Radecki T: Protective action of omeprazole, a benzimidazole derivative, on gastric mucosal damage by aspirin and ethanol in rats. Digestion 27:159?164, 1983","journal-title":"Digestion"},{"key":"CR32","first-page":"59","volume-title":"Problemi di gastroenterologia e ranitidina","author":"SJ Konturek","year":"1984","unstructured":"Konturek SJ: Citoprotezione gastrica negli animali da esperimento e nell'uomo.In Problemi di gastroenterologia e ranitidina, L Barbara, G Dobrilla (eds) Verona, Libreria Cortina, 1984, pp 59?73"},{"key":"CR33","doi-asserted-by":"crossref","unstructured":"Brooks FP, Watkinson G, Davies HC (eds): Prostaglandins in Gastroenterology: Focus on Misoprostol. Dig Dis Sci 30 (Nov Suppl):5S, 1985","DOI":"10.1007\/BF01309378"},{"key":"CR34","unstructured":"Sjostrand SE, Ryberg B, Olbe L: Stimulation and inhibition of acid secretion in the isolated guinea pig gastric mucosa. Acta Physiol Scand (Special Suppl):181?185, 1978"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/290159a0","volume":"290","author":"E Fellenius","year":"1981","unstructured":"Fellenius E, Berglindh T, Sachs G, Olbe L, Elander B, Sjostrand SE, Wallmark B: Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+\/K+)ATPase. Nature 290:159?161, 1981","journal-title":"Nature"},{"key":"CR36","first-page":"G64","volume":"245","author":"B Wallmark","year":"1983","unstructured":"Wallmark B, Jaresten BM, Larsson H, Ryberg B, Brandstrom A, Fellenius E: Differentiation among inhibitory actions of omeprazole, cimetidine, and SCN? on gastric acid secretion. Am J Physiol 245:G64-G71, 1983","journal-title":"Am J Physiol"},{"key":"CR37","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0016-5085(83)80020-1","volume":"85","author":"W Londong","year":"1983","unstructured":"Londong W, Londong V, Cederberg C, Steffen H: Doseresponse study of omeprazole on meal-stimulated gastric acid secretion and gastrin release. Gastroenterology 85:1373?1378, 1983","journal-title":"Gastroenterology"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1476-5381.1983.tb09371.x","volume":"78","author":"SP Canfield","year":"1983","unstructured":"Canfield SP, Spencer JE: The inhibitory effects of 5-hydroxytryptamine on gastric acid secretion by the rat isolated stomach. Br J Pharmacol 78:123?129, 1983","journal-title":"Br J Pharmacol"},{"key":"CR39","doi-asserted-by":"crossref","first-page":"A1","DOI":"10.1111\/j.1365-2362.1983.tb00055.x","volume":"13","author":"HG Damman","year":"1983","unstructured":"Damman HG, Mueller P, Hoelzer P, Simon B: 9-Day omeprazole administration: effects on gastric acid secretion in humans. Eur J Clin Invest 13:A1, 1983","journal-title":"Eur J Clin Invest"},{"issue":"Suppl 86","key":"CR40","first-page":"45","volume":"18","author":"T Lind","year":"1983","unstructured":"Lind T, Jansen JBMJ, Lamers CBH, Moger S, Olbe L: Long-term treatment of Zollinger-Ellison patients with omeprazole. Scand J Gastroenterol 18(Suppl 86):45, 1983","journal-title":"Scand J Gastroenterol"},{"key":"CR41","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3109\/00365528209182245","volume":"17","author":"P Kirkegaard","year":"1982","unstructured":"Kirkegaard P, Christiansen J, Petersen B, Skov Olsen P: Calcium and stimulus-secretion coupling in gastric fundic mucosa. Scand J Gastroenterol 17:533?538, 1982","journal-title":"Scand J Gastroenterol"},{"key":"CR42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000137824","volume":"27","author":"KF Sewing","year":"1983","unstructured":"Sewing KF, Hannemann H: Calcium channel antagonists verapamil and gallopamil are powerful inhibitors of acid secretion in isolated and enriched guinea pig parietal cells. Pharmacology 27:9?14, 1983","journal-title":"Pharmacology"},{"key":"CR43","doi-asserted-by":"crossref","first-page":"969","DOI":"10.3109\/00365528309182124","volume":"18","author":"E Aadland","year":"1983","unstructured":"Aadland E, Berstad A: Effect of verapamil on gastric secretion in man. Scand J Gastroenterol 18:969?971, 1983","journal-title":"Scand J Gastroenterol"},{"key":"CR44","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/clpt.1983.186","volume":"34","author":"RA Levine","year":"1983","unstructured":"Levine RA, Petokas S, Starr A, Eich RH: Effect of verapamil on basal and pentagastrin-stimulated gastric acid secretion. Clin Pharmacol Ther 34:399?402, 1983","journal-title":"Clin Pharmacol Ther"},{"key":"CR45","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/BF00500485","volume":"318","author":"M Spedding","year":"1982","unstructured":"Spedding M: Assessment of Ca++-antagonist effects of drugs in K+-depolarized smooth muscle. Naunyn Schmiedebergs Arch Pharmacol 318:234?240, 1982","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"CR46","first-page":"581","volume-title":"Gut Hormones","author":"NE Gyr","year":"1981","unstructured":"Gyr NE, Kayasseh L, Keller U: Somatostatin as a therapeutic agent.In Gut Hormones SR Bloom, JM Polak (eds). Edinburgh, Churchill Livingstone, 1981, pp 581?585"},{"key":"CR47","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1172\/JCI110838","volume":"71","author":"LE Rosenthal","year":"1983","unstructured":"Rosenthal LE, Yamashiro DJ, Rivier J, Vale W, Brown M: Structure-activity relationships of somatostatin analogs in the rabbit ileum and the rat colon. J Clin Invest 71:840?849, 1983","journal-title":"J Clin Invest"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01309384.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01309384\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01309384","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,6]],"date-time":"2020-04-06T14:19:34Z","timestamp":1586182774000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01309384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,11]]},"references-count":47,"journal-issue":{"issue":"S11","published-print":{"date-parts":[[1985,11]]}},"alternative-id":["BF01309384"],"URL":"https:\/\/doi.org\/10.1007\/bf01309384","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,11]]}}}